Analyst · Hoth Therapeutics, Inc. (HOTH) | Ratings, Price Targets & Consensus

Analyst Consensus

Buy4 analysts

Buy

Updated Jul 27, 2026

Total Analysts4

Buy

4

Ratings

Updated Jul 27, 2026

Overall Rating

C-

DCF Score3.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$0.80

DCF Value-50.60%

$0.40

Potential downside vs current price

Analyst Consensus

Buy4 analysts

Buy

Updated Jul 27, 2026

Total Analysts4

Buy

4

Ratings

Updated Jul 27, 2026

Overall Rating

C-

DCF Score3.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$0.80

DCF Value-50.60%

$0.40

Potential downside vs current price